T 1502/22 (CD33-specific CAR/CELLECTIS) of 25.04.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T150222.20240425
- Date of decision
- 25 April 2024
- Case number
- T 1502/22
- Petition for review of
- -
- Application number
- 15713513.8
- IPC class
- C07K 16/28A61K 39/395A61P 35/02
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- CD33 specific chimeric antigen receptors for cancer immunotherapy
- Applicant name
- Cellectis
- Opponent name
- Wuesthoff & Wuesthoff Patentanwälte PartG mbB
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 83Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)
- Keywords
- Sufficiency of disclosure - Auxiliary request 5 (yes)
Amendment to case - reasons for submitting amendment in appeal proceedings (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent as amended on the basis of the set of claims of auxiliary request 5, submitted with the statement of grounds of appeal, and a description and drawings to be adapted thereto as necessary.